Work Disability and the Cost-effectiveness of Drugs to Treat Rheumatic Diseases - Time for a New Dialogue?

William Tillett; Laura Bojke

doi:10.3899/jrheum.180197

Work Disability and the Cost-effectiveness of Drugs to Treat Rheumatic Diseases - Time for a New Dialogue?

William Tillett
, Laura Bojke

Department of Life Sciences

University of York
Royal National Hospital for Rheumatic Diseases

Research output: Contribution to journal › Article › peer-review

2 Citations (SciVal)

105 Downloads (Pure)

Original language	English
Pages (from-to)	1075-1077
Number of pages	3
Journal	The Journal of Rheumatology
Volume	45
Issue number	8
DOIs	https://doi.org/10.3899/jrheum.180197
Publication status	Published - 1 Aug 2018

ASJC Scopus subject areas

Rheumatology
Immunology and Allergy
Immunology

Access to Document

10.3899/jrheum.180197

Work_Disability_Editorial PDF
This is a pre-copyediting, author-produced PDF of an article accepted for publication in The Journal of Rheumatology following peer review. The definitive publisher-authenticated version Tillett, W & Bojke, L 2018, 'Work Disability and the Cost-effectiveness of Drugs to Treat Rheumatic Diseases - Time for a New Dialogue?' The Journal of Rheumatology, vol. 45, no. 8, pp. 1075-1077 is available online at: http://www.jrheum.org/content/45/8/1075
Accepted author manuscript, 456 KB

Cite this

@article{f0d9867195e9419eafb8511a62dd5df1,

title = "Work Disability and the Cost-effectiveness of Drugs to Treat Rheumatic Diseases - Time for a New Dialogue?",

author = "William Tillett and Laura Bojke",

year = "2018",

month = aug,

day = "1",

doi = "10.3899/jrheum.180197",

language = "English",

volume = "45",

pages = "1075--1077",

journal = "The Journal of Rheumatology",

issn = "0315-162X",